Spoof Access

×
U.S. Flag United States
Financial Advisor
×

Global Equity

The Strategy typically invests opportunistically in both U.S. and foreign stocks.
×

Find a consultant near you to get started

Enter your firm name
Enter a valid 5 digit zip code
* All fields required and intended for Financial Advisor use only
Cumulative Total Returns

as of 7/31/17

Since Inception 2/1/01
335%
Performance & Distributions
×

Global Equity

Gross Expense Ratio:
      0.94%
    Net Expense Ratio:   0.94%

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investments in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the originals cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price and reinvested distributions. Class Y shares are not subject to a sales charge. Returns do not consider capital gains or income taxes on an individual's investment.

    Cumulative Returns
    • A

    Compare to Indices

    Global Opportunities Fund
    VALUE of $10,000.00

    Calendar Year Returns % (w/o sales charge)
    Data as of 8/18/17
      2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YTD
    • B
    Global Opportunities Fund -26.58 57.92 30.36 17.80 11.40 3.98 -41.71 76.38 12.95 -8.98 10.59 41.06 -3.23 14.22 10.95 23.51
    MSCI AC World -16.21 -19.32 33.99 15.23 10.84 20.95 11.66 -42.19 34.63 12.67 -7.35 16.13 22.80 4.16 -2.36 7.86
    Capital Gains Distributions ($ per share)
    Data as of 8/20/17
      2012 2013 2014 2015 2016
    Short Term 0.3151
    Long Term 0.2496 3.1737
    Total Amount of Distribution 0.2496 3.4888
    Record Date 12/10/15 12/8/16
    Ex Div Date 12/11/15 12/9/16
    Pay Date 12/11/15 12/9/16

    There is no guarantee of the payment of any dividend or other distributions at any level.

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investments in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the originals cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price and reinvested distributions. Class Y shares are not subject to a sales charge. Returns do not consider capital gains or income taxes on an individual's investment.

    Average Annual Total Returns
    • A

    as of 7/31/17

    as of 6/30/17

    • A
    YTD (as of 8/18/17)
    • B
    23.51%
    1 Year 33.68%
    3 Year 19.46%
    5 Year 18.85%
    10 Year 9.62%
    Since Inception 9.32%
    YTD (as of 8/18/17)
    • B
    23.51%
    1 Year 33.68%
    3 Year 19.46%
    5 Year 18.85%
    10 Year 9.62%
    Since Inception 9.32%
    YTD (as of 8/18/17)
    • B
    23.51%
    1 Year 39.40%
    3 Year 14.74%
    5 Year 17.40%
    10 Year 9.10%
    Since Inception 9.07%
    YTD (as of 8/18/17)
    • B
    23.51%
    1 Year 39.40%
    3 Year 14.74%
    5 Year 17.40%
    10 Year 9.10%
    Since Inception 9.07%
    Gross Expense Ratio
    0.94%
    NAV
    • C
    as of 8/18/17
    $57.32

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investments in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the originals cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price and reinvested distributions. Class Y shares are not subject to a sales charge. Returns do not consider capital gains or income taxes on an individual's investment.

    Top Issuers

    07/31/17

    Nektar Therapeutics
    9.5%
    Advanced Micro Devices
    4.9%
    Coherent, Inc.
    3.8%
    Genmab A/S
    2.4%
    Nintendo Co. Ltd.
    2.4%
    H. Lundbeck AS
    2.2%
    EXACT Sciences Corp.
    1.7%
    iRobot Corp.
    1.7%
    Applied Materials, Inc.
    1.6%
    Boeing Co.
    1.3%
    Seattle Genetics, Inc.
    1.3%
    Novozymes AS
    1.2%
    Pandora AS
    1.2%
    PTC, Inc.
    1.2%
    MorphoSys AG
    1.2%
    Restoration Hardware Holdings...
    1.2%
    Ci:z Holdings Co. Ltd.
    1.2%
    Ferrovial SA
    1.2%
    SuperGroup plc
    1.1%
    boohoo.com plc
    1.1%
    ×
    • 9.5%
      Nektar Therapeutics
    • Researches and develops inhalation drug delivery systems
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Pharmaceuticals
    MARKET CAP Small
    ×
    • 4.9%
      Advanced Micro Devices
    • Manufactures integrated circuits for semiconductors
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Semiconductors & Semiconductor Equipment
    MARKET CAP Mid
    ×
    • 3.8%
      Coherent, Inc.
    • Manufactures and supplies laser diodes and other laser equipment
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Electronic Equipment Instruments & Components
    MARKET CAP Mid
    ×
    • 2.4%
      Genmab A/S
    • Develops human antibody therapeutics for the treatment of cancer
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Large
    ×
    • 2.4%
      Nintendo Co. Ltd.
    • Engages in the manufacture and sale of home video systems and related software
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Japan
    EQUITY SECTOR Information Technology
    INDUSTRY Software
    MARKET CAP Large
    ×
    • 2.2%
      H. Lundbeck AS
    • Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Health Care
    INDUSTRY Pharmaceuticals
    MARKET CAP Large
    ×
    • 1.7%
      EXACT Sciences Corp.
    • Develops proprietary technologies for the detection of cancer
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Mid
    ×
    • 1.7%
      iRobot Corp.
    • Engages in the business of designing and building robots
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Household Durables
    MARKET CAP Small
    ×
    • 1.6%
      Applied Materials, Inc.
    • Manufactures and markets equipment and software for the semiconductor industries
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Semiconductors & Semiconductor Equipment
    MARKET CAP Large
    ×
    • 1.3%
      Boeing Co.
    • Develops and manufactures jetliners, aircraft and related products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Industrials
    INDUSTRY Aerospace & Defense
    MARKET CAP Large
    ×
    • 1.3%
      Seattle Genetics, Inc.
    • Develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Mid
    ×
    • 1.2%
      Novozymes AS
    • Provides biological solutions and enzyme products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Materials
    INDUSTRY Chemicals
    MARKET CAP Large
    ×
    • 1.2%
      Pandora AS
    • Manufactures and sells jewelry
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Textiles Apparel & Luxury Goods
    MARKET CAP Large
    ×
    • 1.2%
      PTC, Inc.
    • Develops and provides software based product management and development solutions
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Software
    MARKET CAP Mid
    ×
    • 1.2%
      MorphoSys AG
    • Manufactures pharmaceutical products and provides research and development services
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Germany
    EQUITY SECTOR Health Care
    INDUSTRY Life Sciences Tools & Services
    MARKET CAP Mid
    ×
    • 1.2%
      Restoration Hardware Holdings
    • Operates as a holding company with interest in providing luxury home furnishings
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Specialty Retail
    MARKET CAP Small
    ×
    • 1.2%
      Ci:z Holdings Co. Ltd.
    • Engages in the manufacture and sale of cosmetics and skincare products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Japan
    EQUITY SECTOR Consumer Staples
    MARKET CAP Mid
    ×
    • 1.2%
      Ferrovial SA
    • Designs, constructs, operates and maintenance of transport, urban and services infrastructure
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Spain
    EQUITY SECTOR Industrials
    MARKET CAP Large
    ×
    • 1.1%
      SuperGroup plc
    • Designs and sells branded premium quality clothing and accessories for men and women
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United Kingdom
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Specialty Retail
    MARKET CAP Small
    ×
    • 1.1%
      boohoo.com plc
    • Designs and retails clothing
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United Kingdom
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Internet & Direct Marketing Retail
    MARKET CAP Mid
    Holdings Breakdown

    as of 07/31/17

    41.2%

    United States

    11.9%

    United Kingdom

    8.1%

    Japan

    7.8%

    Germany

    7.1%

    Denmark

    4.2%

    France

    No Issuer Equity
    in
    France
    3.6%

    Spain

    3.1%

    Italy

    No Issuer Equity
    in
    Italy
    0.7%

    Canada

    No Issuer Equity
    in
    Canada
    0.7%

    Belgium

    No Issuer Equity
    in
    Belgium
    0.5%

    Portugal

    No Issuer Equity
    in
    Portugal
    0.5%

    Norway

    No Issuer Equity
    in
    Norway
    0.3%

    China

    No Issuer Equity
    in
    China
    0.2%

    Argentina

    No Issuer Equity
    in
    Argentina
    Developed Markets 5
    Emerging Markets 5
    41.9%

    Americas

    No Issuer Equity
    in
    Americas
    39.3%

    Europe

    No Issuer Equity
    in
    Europe
    8.1%

    Asia Pacific

    No Issuer Equity
    in
    Asia Pacific
    0.3%

    Asia Pacific

    No Issuer Equity
    in
    Asia Pacific
    0.2%

    Americas

    No Issuer Equity
    in
    Americas
    27.4%

    Information Technology

    27.2%

    Health Care

    17.9%

    Consumer Discretionary

    12.2%

    Industrials

    3.6%

    Materials

    2.8%

    Financials

    No Issuer Equity
    in
    Financials
    2.8%

    Consumer Staples

    1.7%

    Real Estate

    No Issuer Equity
    in
    Real Estate
    0.5%

    Telecommunication Services

    No Issuer Equity
    in
    Telecommunication Services
    -6.3%

    Broad Market

    No Issuer Equity
    in
    Broad Market
    12.2%

    Pharmaceuticals

    8.0%

    Software

    8.0%

    Semiconductors & Semiconductor Equipment

    6.8%

    Biotechnology

    6.2%

    Electronic Equipment Instruments & Components

    4.1%

    Internet & Direct Marketing Retail

    4.1%

    Textiles Apparel & Luxury Goods

    3.8%

    Health Care Equipment & Supplies

    No Issuer Equity
    in
    Health Care Equipment & Supplies
    3.2%

    Chemicals

    3.2%

    Specialty Retail

    3.1%

    Machinery

    No Issuer Equity
    in
    Machinery
    2.9%

    Life Sciences Tools & Services

    2.8%

    Aerospace & Defense

    2.3%

    Capital Markets

    No Issuer Equity
    in
    Capital Markets
    2.3%

    Household Durables

    2.1%

    Internet Software & Services

    No Issuer Equity
    in
    Internet Software & Services
    2.0%

    Media

    No Issuer Equity
    in
    Media
    1.9%

    Electrical Equipment

    No Issuer Equity
    in
    Electrical Equipment
    1.8%

    Commercial Services & Supplies

    No Issuer Equity
    in
    Commercial Services & Supplies
    1.7%

    Technology Hardware Storage & Peripherals

    No Issuer Equity
    in
    Technology Hardware Storage & Peripherals
    89.8%

    41.9%

    Mid

    29.7%

    Small

    24.6%

    Large

    Risk Measurements

    as of 07/31/17

    Alpha 11.84%
    Beta 1.13
    R-Squared
    53.46
    Sharpe Ratio
    1.14
    Standard Deviation
    16.71%
    Sortino Ratio
    0.55
    Information Ratio
    1.15
    Equity Style
    • D
    Total Assets (all classes)
    as of 7/31/17
    $5.6 BN
    Portfolio Statistics

    as of 7/31/17

    Avg Market Cap (weighted) 11.7 BN
    Median Market Cap (weighted) 5.1 BN
    P/E (next 12 months) 39.96
    Price/Book Value (LTM) 4.74
    Turnover Ratio
    26.00%
    Investment Minimums
    Initial
    $1,000
    Dividends ($ per share)
    • E
    Est Frequency Annual
    Last Pay Date 12/9/16
    Per Share ($) 0.2641
    12-Month Distribution ($) 0.2641
    Distribution Sources
    Net Income 0.00%
    Net Profit from Sale 100.00%
    Other Capital Sources 0.00%
    Top Issuers

    07/31/17

    Nektar Therapeu...
    9.5%
    Advanced Micro ...
    4.9%
    Coherent, Inc.
    3.8%
    Genmab A/S
    2.4%
    Nintendo Co. Lt...
    2.4%
    H. Lundbeck AS
    2.2%
    EXACT Sciences ...
    1.7%
    iRobot Corp.
    1.7%
    Applied Materia...
    1.6%
    Boeing Co.
    1.3%
    Seattle Genetic...
    1.3%
    Novozymes AS
    1.2%
    Pandora AS
    1.2%
    PTC, Inc.
    1.2%
    MorphoSys AG
    1.2%
    Restoration Har...
    1.2%
    Ci:z Holdings C...
    1.2%
    Ferrovial SA
    1.2%
    SuperGroup plc
    1.1%
    boohoo.com plc
    1.1%
    Holdings Breakdown

    as of 07/31/17

    Reset
    41.2%

    United States

    11.9%

    United Kingdom

    8.1%

    Japan

    7.8%

    Germany

    7.1%

    Denmark

    4.2%

    France

    No Issuer Equity
    in
    France
    3.6%

    Spain

    3.1%

    Italy

    No Issuer Equity
    in
    Italy
    0.7%

    Canada

    No Issuer Equity
    in
    Canada
    0.7%

    Belgium

    No Issuer Equity
    in
    Belgium
    0.5%

    Portugal

    No Issuer Equity
    in
    Portugal
    0.5%

    Norway

    No Issuer Equity
    in
    Norway
    0.3%

    China

    No Issuer Equity
    in
    China
    0.2%

    Argentina

    No Issuer Equity
    in
    Argentina
    41.9%

    Americas

    No Issuer Equity
    in
    Americas
    39.3%

    Europe

    No Issuer Equity
    in
    Europe
    8.1%

    Asia Pacific

    No Issuer Equity
    in
    Asia Pacific
    0.3%

    Asia Pacific

    No Issuer Equity
    in
    Asia Pacific
    0.2%

    Americas

    No Issuer Equity
    in
    Americas
    27.4%

    Information Technology

    27.2%

    Health Care

    17.9%

    Consumer Discretionary

    12.2%

    Industrials

    3.6%

    Materials

    2.8%

    Financials

    No Issuer Equity
    in
    Financials
    2.8%

    Consumer Staples

    1.7%

    Real Estate

    No Issuer Equity
    in
    Real Estate
    0.5%

    Telecommunication Services

    No Issuer Equity
    in
    Telecommunication Services
    -6.3%

    Broad Market

    No Issuer Equity
    in
    Broad Market
    12.2%

    Pharmaceuticals

    8.0%

    Software

    8.0%

    Semiconductors & Semiconductor Equipment

    6.8%

    Biotechnology

    6.2%

    Electronic Equipment Instruments & Components

    4.1%

    Internet & Direct Marketing Retail

    4.1%

    Textiles Apparel & Luxury Goods

    3.8%

    Health Care Equipment & Supplies

    No Issuer Equity
    in
    Health Care Equipment & Supplies
    3.2%

    Chemicals

    3.2%

    Specialty Retail

    3.1%

    Machinery

    No Issuer Equity
    in
    Machinery
    2.9%

    Life Sciences Tools & Services

    2.8%

    Aerospace & Defense

    2.3%

    Capital Markets

    No Issuer Equity
    in
    Capital Markets
    2.3%

    Household Durables

    2.1%

    Internet Software & Services

    No Issuer Equity
    in
    Internet Software & Services
    2.0%

    Media

    No Issuer Equity
    in
    Media
    1.9%

    Electrical Equipment

    No Issuer Equity
    in
    Electrical Equipment
    1.8%

    Commercial Services & Supplies

    No Issuer Equity
    in
    Commercial Services & Supplies
    1.7%

    Technology Hardware Storage & Peripherals

    No Issuer Equity
    in
    Technology Hardware Storage & Peripherals
    89.8%

    41.9%

    Mid

    29.7%

    Small

    24.6%

    Large

    ×
    • 9.5%
      Nektar Therapeutics
    • Researches and develops inhalation drug delivery systems
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Pharmaceuticals
    MARKET CAP Small
    ×
    • 4.9%
      Advanced Micro Devices
    • Manufactures integrated circuits for semiconductors
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Semiconductors & Semiconductor Equipment
    MARKET CAP Mid
    ×
    • 3.8%
      Coherent, Inc.
    • Manufactures and supplies laser diodes and other laser equipment
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Electronic Equipment Instruments & Components
    MARKET CAP Mid
    ×
    • 2.4%
      Genmab A/S
    • Develops human antibody therapeutics for the treatment of cancer
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Large
    ×
    • 2.4%
      Nintendo Co. Ltd.
    • Engages in the manufacture and sale of home video systems and related software
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Japan
    EQUITY SECTOR Information Technology
    INDUSTRY Software
    MARKET CAP Large
    ×
    • 2.2%
      H. Lundbeck AS
    • Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Health Care
    INDUSTRY Pharmaceuticals
    MARKET CAP Large
    ×
    • 1.7%
      EXACT Sciences Corp.
    • Develops proprietary technologies for the detection of cancer
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Mid
    ×
    • 1.7%
      iRobot Corp.
    • Engages in the business of designing and building robots
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Household Durables
    MARKET CAP Small
    ×
    • 1.6%
      Applied Materials, Inc.
    • Manufactures and markets equipment and software for the semiconductor industries
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Semiconductors & Semiconductor Equipment
    MARKET CAP Large
    ×
    • 1.3%
      Boeing Co.
    • Develops and manufactures jetliners, aircraft and related products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Industrials
    INDUSTRY Aerospace & Defense
    MARKET CAP Large
    ×
    • 1.3%
      Seattle Genetics, Inc.
    • Develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Health Care
    INDUSTRY Biotechnology
    MARKET CAP Mid
    ×
    • 1.2%
      Novozymes AS
    • Provides biological solutions and enzyme products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Materials
    INDUSTRY Chemicals
    MARKET CAP Large
    ×
    • 1.2%
      Pandora AS
    • Manufactures and sells jewelry
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Denmark
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Textiles Apparel & Luxury Goods
    MARKET CAP Large
    ×
    • 1.2%
      PTC, Inc.
    • Develops and provides software based product management and development solutions
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Information Technology
    INDUSTRY Software
    MARKET CAP Mid
    ×
    • 1.2%
      MorphoSys AG
    • Manufactures pharmaceutical products and provides research and development services
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Germany
    EQUITY SECTOR Health Care
    INDUSTRY Life Sciences Tools & Services
    MARKET CAP Mid
    ×
    • 1.2%
      Restoration Hardware Holdings
    • Operates as a holding company with interest in providing luxury home furnishings
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United States
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Specialty Retail
    MARKET CAP Small
    ×
    • 1.2%
      Ci:z Holdings Co. Ltd.
    • Engages in the manufacture and sale of cosmetics and skincare products
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Japan
    EQUITY SECTOR Consumer Staples
    MARKET CAP Mid
    ×
    • 1.2%
      Ferrovial SA
    • Designs, constructs, operates and maintenance of transport, urban and services infrastructure
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY Spain
    EQUITY SECTOR Industrials
    MARKET CAP Large
    ×
    • 1.1%
      SuperGroup plc
    • Designs and sells branded premium quality clothing and accessories for men and women
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United Kingdom
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Specialty Retail
    MARKET CAP Small
    ×
    • 1.1%
      boohoo.com plc
    • Designs and retails clothing
      Source: FactSet
    ASSET ALLOCATION Equity
    COUNTRY United Kingdom
    EQUITY SECTOR Consumer Discretionary
    INDUSTRY Internet & Direct Marketing Retail
    MARKET CAP Mid

    Management

    Frank Jennings, Ph.D.

    Managed Fund since 10/95

    Investment Approach

    The portfolio manager invests in companies he believes will gain a greater share of global GDP. At the highest level, we categorize these structural themes into the rubric MANTRA®: Mass Affluence, New Technology, Restructuring and Aging. Sub-themes are concentrated in 21st century industries and favor intellectual property-based areas of the market. Fundamental analysis guides the bottom-up approach to security selection.

    Risk Management

    Our team limits exposure to individual companies, industries and sectors, seeking to limit volatility through company quality and diversification. Risk Management Overview

    We conduct rigorous fundamental research to identify individual companies with asymmetrical risk/return opportunities. Risk Management Overview

    At the portfolio level, our experienced investment personnel closely monitor the strategy's positioning, and the active risk resulting from our security selection process and sector allocations. We evaluate factor and style exposure, as well as the ownership and liquidity profile of each security in the portfolio. Risk Management Overview

    Our team proactively manages risk by constructing diversified portfolios across sectors, industry groups and securities. We manage, monitor and limit sector weights relative to specified benchmarks and security position sizes within each portfolio. Risk Management Overview

    Our team closely monitors position size and sector weights; we have limits on active security weights against the benchmark for each strategy we manage. Risk Management Overview

    Risk is managed at the portfolio, strategy and security levels to identify diversified sources of alpha. We mainly focus on currency, interest rates and credit. Positions are sized and monitored according to established limits. Risk Management Overview

    We focus primarily on senior loans in an effort to maintain product integrity and limit duration risk. Risk Management Overview

    The team manages risk at both a strategy and individual security level to help ensure that, when combined, they act as the ballast in an investor’s overall portfolio. Risk Management Overview

    Risk is managed at the portfolio, strategy and security levels to identify diversified sources of alpha. We seek to identify primary and secondary risks of each investment. Diversification of sectors can potentially reduce volatility. Risk Management Overview

    The team manages risk by administering duration limits, limiting portfolio weighted average maturity and conducting thorough credit analysis on individual securities. Risk Management Overview

    The Rochester team has created diverse portfolios designed to mitigate the types of risks that municipal bond investors may encounter. Risk Management Overview

    The Commodities team manages risk on multiple levels, including individual commodity sector levels and overall fund level. Risk Management Overview

    The Real Estate team monitors and manages risk at the security, sector and strategy levels. Risk Management Overview

    The Global Multi-Asset Group monitors and manages risk on an ongoing basis, both at the asset class and portfolio levels. Risk Management Overview

    We emphasize capital preservation by avoiding companies that may cut distributions. We seek to build diversified portfolios comprised of energy and energy related companies with attractive risk-adjusted total return potential. Risk Management Overview

    The Alternative Strategies team evaluates risk on multiple levels, applying numerous risk analysis methods on an ongoing basis in addition to assessing risk impacts of a position prior to making investment decisions. Risk Management Overview

    Risk is monitored by quantitative risk system and managed at many levels – stock, sector, country, and style factors. We seek to diversify the portfolio across the global listed infrastructure market and adhere to an established risk framework, including constraints imposed by position limits versus a benchmark. Risk Management Overview

    We monitor and manage both security and sector weights to the underlying index to ensure that the portfolio is properly tracking its benchmark. Also, partnering with well-known index providers ensures that we hold only high quality securities that pass very stringent profitability and liquidity screens. Risk Management Overview

    ×
    1. 1. Special Risks: Foreign investments may be volatile and involve additional expenses and special risks, including currency fluctuations, foreign taxes, regulatory and geopolitical risks. Emerging and developing market investments may be especially volatile. Eurozone investments may be subject to volatility and liquidity issues. Investments in securities of growth companies may be volatile. Mid-sized company stock is typically more volatile than that of larger company stock. It may take a substantial period of time to realize a gain on an investment in a mid-sized company, if any gain is realized at all. Fixed income investing entails credit and interest rate risks. When interest rates rise, bond prices generally fall, and the Fund’s share prices can fall. Below-investment-grade (“high yield” or "junk") bonds are more at risk of default and are subject to liquidity risk. Diversification does not guarantee profit or protect against loss.
    2. 2. The net expense ratio (where applicable) also takes into account contractual fee waivers and/or expense reimbursements without which performance would have been less. These undertakings may not be amended or withdrawn for one year from the date of the current prospectus, unless approved by the Board.
    3. 3. For Share Classes with less than a one-year track record, expense ratios are estimated based on the Manager's projections of those expenses for the coming fiscal year.
    4. 4. Access index definitions.
    5. 5. Holdings are subject to change, and are dollar weighted based on total net assets. Negative weightings may result from the use of leverage. Leverage involves the use of various financial instruments or borrowed capital in an attempt to increase investment return. Leverage risks include potential for higher volatility, greater decline of the fund's net asset value and fluctuations of dividends and distributions paid by the fund.
    6. 6. Holdings are subject to change, are dollar-weighted based on assets, and may not reflect the use of leverage in the Fund. Market Cap breakdown is calculated using Morningstar's methodology and those capitalization standards may not align with those in the Fund’s prospectus.
    7. A. The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investments in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the originals cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price and reinvested distributions. Class Y shares are not subject to a sales charge. Returns do not consider capital gains or income taxes on an individual's investment.
    8. B. "Year to Date" returns are cumulative, not annualized, and do not reflect sales charges (if sales charges are applicable to the Fund). These returns would be lower if sales charges were taken into consideration. Short-term returns may not be indicative of longer-term performance, which should also be considered when making investment decisions.
    9. C. Daily net asset value and dollar change of the fund is as of the previous business day's closing. Fund net asset values are updated at approximately 7:00pm ET daily.
    10. D. OppenheimerFunds' equity style box is based on the portfolio's overall targeted capitalization range and relative valuation as determined by OFI.
    11. E. There is no guarantee of the payment of any dividend or other distributions at any level.
    ×
    Loading...
    Tiny Button Small Button Large Button Default Button Secondary Button Framed Button Framed Button ( Small Caps )